A
A

Financials • Artiva Biotherapeutics

ARTV

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

12/2023
1 financial
12/2023
Year
12/2023
33
-28
-28
L
-162
L
-60
-
-54
-3
24
-58
L

To see all financials—including updated, you must be Premium.